MARKET IS CLOSED
Loading latest tickers...

Market Indices

S&P 500
$7,801.77
-0.22%
NASDAQ 100
$31,160.08
-0.21%
DOW JONES
$51,180.00
-0.66%
NASDAQ Composite
$27,538.69
-0.22%
RUSSELL 2000
$2,777.00
-1.29%
CBOE VIX
$15.08
+0.47%

Sector Heatmap

Technology-0.30%
Financials-0.48%
Healthcare+1.03%
Consumer Cycl-0.32%
Consumer Staples-0.12%
Energy-0.58%
Industrials-2.18%
Materials-1.51%
Real Estate-1.29%
Utilities-0.02%
Comm Services-0.35%

PBH — Prestige Consumer Healthcare Inc.

NYSE

Prestige Consumer Healthcare Inc.

CompareBack to Screener
$47.57
+1.13(+2.43%)
O
46.57
H
47.72
L
46.34
V
460.85K
⏱️ End-of-day dataAs of Oct 7, 2026

Chart

About PBH

Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige's key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer's Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.

IndustryPHARMACEUTICAL PREPARATIONS
SectorNot available
IPO DateFeb 10, 2005
Employees890
Stock ExchangeNYSE
Ticker SymbolPBH

Key Financial Statistics

Market Cap$2.14B
P/E RatioN/A
Dividend YieldNone
EPSN/A
BetaN/A
52-Week Range$42.62 - $71.07
52-Week Avg Volume531.4K
VWAP$47.30
Transactions10,647
Total Recorded Bars5,447 days